Name : APOC2 Antibody, Cy7 Conjugated
Supplier : BIOSS PRIMARY CONJUGATED ANTIBODIES 1
Price :350
SKU : GEN4031011073
| Long name | Cy7 Conjugated, APOC2 Polyclonal Antibody |
| Category | Conjugated Primary Antibodies |
| Conjugation | Cy7 |
| Host Organism | Rabbit (Oryctolagus cuniculus) |
| Target Antigen | APOC2 |
| Specificity | This is a highly specific antibody against APOC2 |
| Modification | Unmodified |
| Modification site | None |
| Clonality | Polyclonal |
| Clone | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Source | KLH conjugated synthetic peptide derived from human APOC2 |
| Gene ID number | 344 |
| Tested applications | IF(IHC-P) |
| Recommended dilutions | IF(IHC-P)(1:50-200) |
| Crossreactivity | Mouse, Rat, Human |
| Crossreactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Antigen background | ApoCII activates the enzyme lipoprotein lipase, which hydrolyzes triglycerides and thus provides free fatty acids for cells, Apolipoprotein C-II (apoCII) is in found in chylomicrons (large lipoprotein particles absorbed from the gastrointestinal tract) and VLDL (large lipoproteins that are broken down to eventually form LDL) |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA |
| Excitation Emission | 743nm/767nm |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24° |
| Conjugated | These antibodies are excite for emission at 650 nm and detected at a 676 nm wavelengths |
| Gene target | APOC2 Conjugated |
| Short name | Conjugated, APOC2 Antibody |
| Technique | antibodies against human proteins, antibodies for, antibody Conjugates, Antibody |
| Label | Cy7 |
| Alternative name | cyanine 7 coupled, apolipoprotein C-II (Antibody to) |
| Alternative technique | antibodies |
| Alternative to gene target | APO-CII and APOC-II, APOC2 and IDBG-306903 and ENSG00000234906 and 344, APOC2 and IDBG-639315 and ENSBTAG00000020558 and 618039, Apoc2 and IDBG-151996 and ENSMUSG00000002992 and 11813, Extracellular, lipoprotein lipase activator activity, this GO :0001523 and retinoid metabolic process and biological process this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005769 and early endosome and cellular component this GO :0006629 and lipid metabolic process and biological process this GO :0006869 and lipid transport and biological process this GO :0007603 and phototransduction, this GO :0008047: enzyme activator activity, this GO :0008047: enzyme activator activity and also this GO :0008289: lipid binding and also this GO :0016004: phospholipase activator activity and also this GO :0042803: protein homodimerization activity and also this GO :0043274: phospholipase binding and also this GO :0055102: lipase inhibitor activity and also this GO :0060230: lipoprotein lipase activator activity, this GO :0008289: lipid binding, this GO :0016004: phospholipase activator activity, this GO :0042803: protein homodimerization activity, this GO :0043274: phospholipase binding, this GO :0055102: lipase inhibitor activity, this GO :0060230: lipoprotein lipase activator activity, visible light and biological process this GO :0008047 and enzyme activator activity and molecular function this GO :0008289 and lipid binding and molecular function this GO :0010518 and positive regulation of phospholipase activity and biological process this GO :0010898 and positive regulation of triglyceride catabolic process and biological process this GO :0010902 and positive regulation of very-low-density lipoprotein particle remodeling and biological process this GO :0010916 and negative regulation of very-low-density lipoprotein particle clearance and biological process this GO :0016004 and phospholipase activator activity and molecular function this GO :0016042 and lipid catabolic process and biological process this GO :0032375 and negative regulation of cholesterol transport and biological process this GO :0033344 and cholesterol efflux and biological process this GO :0033700 and phospholipid efflux and biological process this GO :0034361 and very-low-density lipoprotein particle and cellular component this GO :0034362 and low-density lipoprotein particle and cellular component this GO :0034363 and intermediate-density lipoprotein particle and cellular component this GO :0034366 and spherical high-density lipoprotein particle and cellular component this GO :0034370 and triglyceride-rich lipoprotein particle remodeling and biological process this GO :0034371 and chylomicron remodeling and biological process this GO :0034372 and very-low-density lipoprotein particle remodeling and biological process this GO :0034382 and chylomicron remnant clearance and biological process this GO :0034384 and high-density lipoprotein particle clearance and biological process this GO :0042157 and lipoprotein metabolic process and biological process this GO :0042627 and chylomicron and cellular component this GO :0042632 and cholesterol homeostasis and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0043085 and positive regulation of catalytic activity and biological process this GO :0043086 and negative regulation of catalytic activity and biological process this GO :0043274 and phospholipase binding and molecular function this GO :0043691 and reverse cholesterol transport and biological process this GO :0044281 and small molecule metabolic process and biological process this GO :0045723 and positive regulation of fatty acid biosynthetic process and biological process this GO :0045833 and negative regulation of lipid metabolic process and biological process this GO :0048261 and negative regulation of receptor-mediated endocytosis and biological process this GO :0051006 and positive regulation of lipoprotein lipase activity and biological process this GO :0055102 and lipase inhibitor activity and molecular function this GO :0060230 and lipoprotein lipase activator activity and molecular function this GO :0060697 and positive regulation of phospholipid catabolic process and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0070328 and triglyceride homeostasis and biological process, apolipoprotein C-II |
| Identity | 609 |
| Gene | APOC2 |
| Long gene name | apolipoprotein C2 |
| Synonyms gene name | apolipoprotein C-II |
| Locus | 19q13, 32 |
| Discovery year | 2001-06-22 |
| GenBank acession | X00568 |
| Entrez gene record | 344 |
| RefSeq identity | NM_000483 |
| Classification | Apolipoproteins |
| Havana BLAST/BLAT | OTTHUMG00000180847 |